230 related articles for article (PubMed ID: 34415547)
1. An Insilico evaluation of phytocompounds from Albizia amara and Phyla nodiflora as cyclooxygenase-2 enzyme inhibitors.
Loganathan Y; Jain M; Thiyagarajan S; Shanmuganathan S; Mariappan SK; Kizhakedathil MPJ; Saravanakumar T
Daru; 2021 Dec; 29(2):311-320. PubMed ID: 34415547
[TBL] [Abstract][Full Text] [Related]
2. Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation.
Razzaghi-Asl N; Mirzayi S; Mahnam K; Sepehri S
J Mol Graph Model; 2018 Aug; 83():138-152. PubMed ID: 29936228
[TBL] [Abstract][Full Text] [Related]
3. Rational Druggability Investigation Toward Selection of Lead Molecules: Impact of the Commonly Used Spices on Inflammatory Diseases.
Zakerali T; Shahbazi S
Assay Drug Dev Technol; 2018 Oct; 16(7):397-407. PubMed ID: 30106307
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of in vitro and in silico anti-inflammatory potential of some selected medicinal plants of Bangladesh against cyclooxygenase-II enzyme.
Islam MA; Zilani MNH; Biswas P; Khan DA; Rahman MH; Nahid R; Nahar N; Samad A; Ahammad F; Hasan MN
J Ethnopharmacol; 2022 Mar; 285():114900. PubMed ID: 34896569
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking study and molecular dynamic simulation of human cyclooxygenase-2 (COX-2) with selected eutypoids.
Taidi L; Maurady A; Britel MR
J Biomol Struct Dyn; 2022 Feb; 40(3):1189-1204. PubMed ID: 32990169
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches.
Cruz JV; Giuliatti S; Alves LB; Silva RC; Ferreira EFB; Kimani NM; Silva CHTP; Souza JSN; Espejo-Román JM; Santos CBR
J Biomol Struct Dyn; 2022 Aug; 40(12):5386-5408. PubMed ID: 33427075
[TBL] [Abstract][Full Text] [Related]
7. Discovery of andrographolide hit analog as a potent cyclooxygenase-2 inhibitor through consensus MD-simulation, electrostatic potential energy simulation and ligand efficiency metrics.
Jain P; Satija J; Sudandiradoss C
Sci Rep; 2023 May; 13(1):8147. PubMed ID: 37208387
[TBL] [Abstract][Full Text] [Related]
8. Computational screening of potential anti-inflammatory leads from Jeevaneeya Rasayana plants targeting COX-2 and 5- LOX by molecular docking and dynamic simulation approaches.
Hemavathi KN; Skariyachan S; Raju R; Keshava Prasad TS; Abhinand CS
Comput Biol Med; 2024 Mar; 171():108164. PubMed ID: 38412690
[TBL] [Abstract][Full Text] [Related]
9. Screening cyclooxygenase-2 inhibitors from Allium sativum L. compounds: in silico approach.
Sadeghi M; Miroliaei M; Fateminasab F; Moradi M
J Mol Model; 2021 Dec; 28(1):24. PubMed ID: 34970708
[TBL] [Abstract][Full Text] [Related]
10. Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs.
Bommu UD; Konidala KK; Pamanji R; Yeguvapalli S
Interdiscip Sci; 2019 Jun; 11(2):153-169. PubMed ID: 29236213
[TBL] [Abstract][Full Text] [Related]
11. Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulations.
Mude L; Jupudi S; Swaroop AK; Tallapaneni V; Karri VVSR
J Biomol Struct Dyn; 2024 Mar; 42(5):2437-2448. PubMed ID: 37160705
[TBL] [Abstract][Full Text] [Related]
12. The bitter barricading of prostaglandin biosynthesis pathway: understanding the molecular mechanism of selective cyclooxygenase-2 inhibition by amarogentin, a secoiridoid glycoside from Swertia chirayita.
Shukla S; Bafna K; Sundar D; Thorat SS
PLoS One; 2014; 9(6):e90637. PubMed ID: 24603686
[TBL] [Abstract][Full Text] [Related]
13. Insights into cyclooxygenase-2 inhibition by isolated bioactive compounds 3-caffeoyl-4-dihydrocaffeoyl quinic acid and isorhamnetin 3-O-β-D-glucopyranoside from Salicornia herbacea.
Bahuguna A; Bharadwaj S; Bajpai VK; Shukla S; Won DW; Park I; Na M; Sonwal S; Huh YS; Han YK; Simal-Gandara J; Xiao J; Kim M
Phytomedicine; 2021 Sep; 90():153638. PubMed ID: 34275700
[TBL] [Abstract][Full Text] [Related]
14. A hybrid platform featuring nanomagnetic ligand fishing for discovering COX-2 selective inhibitors from aerial part of Saussurea laniceps Hand.-Mazz.
Chen Q; Zhu L; Yip KM; Tang Y; Liu Y; Jiang T; Zhang J; Zhao Z; Yi T; Chen H
J Ethnopharmacol; 2021 May; 271():113849. PubMed ID: 33485983
[TBL] [Abstract][Full Text] [Related]
15. The structure of NS-398 bound to cyclooxygenase-2.
Vecchio AJ; Malkowski MG
J Struct Biol; 2011 Nov; 176(2):254-8. PubMed ID: 21843643
[TBL] [Abstract][Full Text] [Related]
16. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
17. Identification of tyrosine kinase inhibitors from Panax bipinnatifidus and Panax pseudoginseng for RTK-HER2 and VEGFR2 receptors, by in silico approach.
Paul D; Mahanta S; Tag H; Das SK; Das Gupta D; Tanti B; Ananthan R; Das R; Jambhulkar S; Hui PK
Mol Divers; 2022 Aug; 26(4):1933-1955. PubMed ID: 34554395
[TBL] [Abstract][Full Text] [Related]
18. Exploring molecular docking with MM-GBSA and molecular dynamics simulation to predict potent inhibitors of cyclooxygenase (COX-2) enzyme from terpenoid-based active principles of
Nayak A; Gadnayak A; Dash KT; Jena S; Ray A; Nayak S; Sahoo A
J Biomol Struct Dyn; 2023 Dec; 41(20):10840-10850. PubMed ID: 36576262
[TBL] [Abstract][Full Text] [Related]
19.
Lala M; Bhattacharjee S; Ghosh C; Sen A; Sarkar I
J Biomol Struct Dyn; 2023 May; 41(8):3511-3523. PubMed ID: 35297321
[TBL] [Abstract][Full Text] [Related]
20. Comparative structural study of selective and non-selective NSAIDs against the enzyme cyclooxygenase-2 through real-time molecular dynamics linked to post-dynamics MM-GBSA and e-pharmacophores mapping.
Ganai SA; Rajamanikandan S; Shah BA; Lone A; Arwa F; Malik FA
J Mol Model; 2023 May; 29(6):192. PubMed ID: 37256432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
